Australian Clinical Labs Ltd (AU:ACL) has released an update.
Investors Mutual Limited has become a substantial holder in Australian Clinical Labs Ltd, with a 5.84% stake as of November 21, 2024. This initial substantial holding was announced through a regulatory filing with the ASX detailing the exact number of voting shares acquired. The acquisition marks a significant investment move by Investors Mutual, reflecting their confidence in the future of Australian Clinical Labs.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
